Revenue
$63.31B
Gross Margin
+69.3%
Operating Margin
+23.4%
Net Margin
+11.8%
Income statement waterfall for Pfizer (PFE) — TTM through Q1 2026
Net income: $7.49B
Margin breakdown for Pfizer (PFE) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $63.31B | $63.31B |
| Cost of Revenue | −$19.41B | $43.91B |
| Gross Profit | $43.91B | $43.91B |
| Operating Expenses | −$29.06B | $14.85B |
| Operating Income | $14.85B | $14.85B |
| Other Income / Expense | −$6.94B | $7.91B |
| Pre-tax Income | $7.91B | $7.91B |
| Income Tax | −$384.00M | $7.52B |
| Net Income | $7.49B | $7.49B |
- Revenue$63.31B
- Cost of Revenue−$19.41B
- Gross Profit$43.91B
- Operating Expenses−$29.06B
- Operating Income$14.85B
- Other Income / Expense−$6.94B
- Pre-tax Income$7.91B
- Income Tax−$384.00M
- Net Income$7.49B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement